University of Oregon
Eugene, Oregon, 97403, United States
NCT Number: NCT02971072
The purpose of this study is to examine deficits in activation and motor patterns, as well as central drive in patients with rotator cuff tendinopathy. There are three specific aims: (1) determine the effect of acute pain relief on rotator cuff muscle activation in patients with rotator cuff tendinopathy, (2) determine the effect of exercise on rotator cuff muscle activation in patients with rotator cuff tendinopathy, and (3) compare rotator cuff muscle activation between patients with rotator cuff tendinopathy and healthy controls.
Looking for future studies?
Notify Me21 year–45 year
All sexes
Interventional
Not applicable
Eugene, Oregon, 97403, United States
The long-term goal of our research agenda is to identify the mechanisms associated with rotator cuff tendinopathy (impingement syndrome) and subsequently evaluate novel treatment strategies that address these mechanisms. The objectives of this application are to study the muscle patterns in patients with rotator cuff tendinopathy as well as the effects of both pain and exercise on these patterns. Our first hypothesis is that pain relief from a shoulder injection will result in increased rotator cuff activity. Our second hypothesis is that patients with tendinopathy will demonstrate improved rotator cuff muscle activity following a six-week exercise program and that this improvement will be higher in patients that respond favorably to treatment. Our final hypothesis is that patients with cuff tendinopathy will show decreased rotator cuff activity compared to healthy subjects. The investigators plan on addressing these hypotheses using several novel techniques for muscle activity assessment.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Patient Inclusion Criteria:
Patient Exclusion Criteria:
Control Inclusion Criteria:
Control Exclusion Criteria:
A subacromial injection consisting up 6 cc 0.5% Marcaine with Epinephrine and 1 cc DepoMedrol will be administered.
A standardized six-week exercise protocol supervised by a physical therapist
Time frame: 6 weeks
Assessed using voluntary activation
Time frame: 6 weeks
Assessed using electromyography (EMG)
Time frame: 2 hours
Assessed using voluntary activation
Time frame: 2 hours
Assessed using EMG
Time frame: 2 hours
Assessed using voluntary activation relative to self-reported pain level
Time frame: 2 hours
Assessed using EMG relative to self-reported pain level
Time frame: 6 weeks
Assessed using voluntary activation
Time frame: 6 weeks
Assessed using EMG
Time frame: 6 weeks
Assessed using voluntary activation relative to self-reported pain relief
Time frame: 6 weeks
Assessed using voluntary activation relative to changes in questionnaire scores
Time frame: 6 weeks
Assessed using EMG relative to self-reported pain relief
Time frame: 6 weeks
Assessed using EMG relative to changes in questionnaire scores
Time frame: 6 weeks
Assessed using voluntary activation
Time frame: 6 weeks
Assessed using EMG
Time frame: 6 weeks
Assessed using voluntary activation
Time frame: 6 weeks
Assessed using EMG
University of Oregon
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06968546
Acute Pain, Agnosia
Nice, France
View Trial DetailsNCT07335159
Acute Pain, Agnosia
Tallahassee, Florida, United States
View Trial DetailsNCT07511400
Acute Pain, Common Cold
Vienna, State of Vienna, Austria
View Trial DetailsNCT00233844
Acute Pain, Neurologic Manifestations
View Trial Details